In this regard, the ability of ATH-1105 to induce anti-inflammatory effects in cultured immune cells, such as reduction of NLRP3 expression and IL-1β secretion, provides another mechanism by which ATH-1105 may mitigate ALS pathology. The gene discussed is NLRP3; the disease is amyotrophic lateral sclerosis.